Category: Monteris Medical
OrthoSensor picks up another $13 million, taking its Series B total to $48 million for its Verasense knee replacement device following CE Mark approval in the European Union.
OrthoSensor said it added $13 million to its Series B round, taking the total for the round to $48 million as it looks to capitalize on regulatory nods for its Verasense knee replacement device in the U.S. and Europe.
Monteris Mecical scores regulatory wins in the U.S. and in Canada, also touting positive clinical trial results for the NeuroBlate MRI-guided brain tumor treatment system.
Monteris Medical won a regulatory nod in the U.S. and in Canada for its NeuroBlate MRI-guided tumor ablation device, the company said.
Monteris Medical raises $7.8 million, saying it plans to boost marketing of its NeuroBlate neurosurgical ablation device.
Monteris Medical closed a $7.8 million funding round it plans to use to commercialize its NeuroBlate neurosurgical ablation device for treating brain tumors.
The round, led by Business Development Bank of Canada, also included the SWMF Life Science Fund and several independent parties. Monteris drummed up $9 million last May, according to a press release.
MFS Investment Management, which invented the mutual fund, adds 7 million shares to its stake in St. Jude Medical, taking its share to 10% of the medical device maker; also, Smith & Nephew's Bioventus ortho-biologics JV fledges, Kalypto deal closes; Kerberos Proximal Solutions puts Rinspiration on the auction block; NeuroLogica helps develop 1st mobile stroke ambulance; Xtend Medical gets into the entertainment game; plus, a Funding Roundup and analysts' ups and downs.
St. Jude Medical's (NYSE:STJ) largest investor boosted its stake by more than 30%, to some 27.2 million shares, or about 10% of the medical device maker.
, Bioventus LLC
, Edwards Lifesciences
, Kalypto Medical
, Kerberos Proximal Solutions
, Medical Care Technologies
, Meytec GmbH
, Monteris Medical
, NeuroLogica Corp.
, Orthosensor Inc.
, Smith & Nephew
, St. Jude Medical
, Stereotaxis Inc.
, XTend Medical
CardioInsight chairman & CEO Steve Arless resigns, to be replaced by 2-man "office of the president"; Medical Action Industries shuffles the deck; Monteris Medical appoints John Schellhorn president & CEO; AirXpanders expands its leadership team; Pathway Genomics builds a scientific advisory board; Cleveland Medical Mart builds industry advisory board, names leaders; Zeltiq CEO Gordie Nye steps down; and more.
CardioInsight chairman & CEO Steve Arless resigns, to be replaced by 2-man "office of the president"
Monteris Medical Inc. raises $3.4 million in an equity offering to fuel the sales operation for its AutoLITT neurosurgical laser, designed to reduce brain tumors to paste.
By Brandon Glenn
Monteris Medical Inc. raised $3.4 million in an equity round for a device that enables minimally invasive laser surgery for brain tumors, according to a regulatory filing.
Monteris hopes to stretch the funding round to about $4.5 million, CEO Jim Duncan said. The 25-employee company has garnered $21 million in investment funding since its 1999 inception.